High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?

In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus , an opportunistic fungal pathogen

(2016) S. Khodavaisy et al.   JOURNAL DE MYCOLOGIE MEDICALE

Genotyping of clinical and environmentalAspergillus flavusisolates from Iran using microsatellites

(2016) Sadegh Khodavaisy et al.   MYCOSES

First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France

(2015) Rose-Anne Lavergne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nationwide Surveillance of Azole Resistance in Aspergillus Diseases

(2015) Edith Vermeulen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diagnosis and management of aspergillosis in the Netherlands: a national survey

(2015) Pieter P. A. Lestrade et al.   MYCOSES

First Detection of TR46/Y121F/T289A and TR34/L98H Alterations in Aspergillus fumigatus Isolates from Azole-Naive Patients in Denmark despite Negative Findings in the Environment

(2014) K. M. T. Astvad et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients

(2014) J. Fischer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania

(2014) A. Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Simple, Low-Cost Molecular Assays for TR34/L98H Mutations in the cyp51A Gene for Rapid Detection of Triazole-Resistant Aspergillus fumigatus Isolates

(2014) S. Ahmad et al.   JOURNAL OF CLINICAL MICROBIOLOGY

cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany

(2013) Oliver Bader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles

(2013) Jan W. M. van der Linden et al.   CLINICAL INFECTIOUS DISEASES

Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India

(2013) A. Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Environmental study of azole-resistantAspergillus fumigatuswith TR34/L98H mutations in thecyp51A gene in Iran

(2013) Hamid Badali et al.   MYCOSES

Environmental fungicides and triazole resistance inAspergillus

(2013) Paul Bowyer et al.   PEST MANAGEMENT SCIENCE

Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus

(2012) Paul Bowyer et al.   FEMS MICROBIOLOGY LETTERS

Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India

(2012) Anuradha Chowdhary et al.   PLoS One

Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing

(2012) Simone M. T. Camps et al.   PLoS One

Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms incyp51A, Upregulation ofcyp51A, and Integration and Activation of TransposonAtf1in thecyp51APromoter

(2011) Ahmed M. Albarrag et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene

(2011) Shawn R. Lockhart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India

(2011) A. Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

(2011) K. Tamura et al.   MOLECULAR BIOLOGY AND EVOLUTION

Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain

(2010) K. L. Mortensen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

(2010) A. Bueid et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

(2010) A. Espinel-Ingroff et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence

(2010) Maiken Cavling Arendrup et al.   PLoS One

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Efflux-Mediated Antifungal Drug Resistance

(2009) R. D. Cannon et al.   CLINICAL MICROBIOLOGY REVIEWS

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

(2009) Paul E Verweij et al.   LANCET INFECTIOUS DISEASES

Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

(2008) J. L. Rodriguez-Tudela et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE